Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Revvity share price today

Revvity, Inc. · RVTY · Healthcare · Diagnostics & Research · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Revvity share price: $159.43 at the close on 4 November 2026, +75.6% in a year.

Getting worseBusiness trend from the last 12 quarters
$159.43Price +75.6% in a year
70.6×P/E higher than 86% of the last 4.6 years
$730 MRevenue (Jul 2026) +1.3% on a year ago
$51.8 MProfit (Jul 2026) −3.9% on a year ago
17.1%Operating margin +2.8 points on a year ago
3%ROE FY25
4.5%ROIC against a 9.3% cost of capital: −4.8 points

Revvity, Inc.'s share price has risen faster than its earnings: +75.6% in a year, against −5.8% for earnings per share.

The main question: the share price moved +75.6% in a year while yearly earnings per share moved −5.8%. The difference came from the market paying a higher multiple.

The price has been rising for 19 weeks, and the P/E is higher than 86% of its own last 4.6 years. Over the last four quarters, results have been improving, with profit −3.9% on a year earlier, and 108% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the Revvity share price today?

Revvity, Inc.'s share price was $159.43 at the close on 4 November 2026. It has been rising for 19 weeks. That is 41.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between $84 and $159, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Revvity, Inc. is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 22 weeks in a row.

1Y

Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.

  • Price $159.43
  • 50-day avg $146.52
  • 200-day avg $112.56
Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$93.59$89.78$98.38
7 Nov 2025$90.78$89.82$97.63
14 Nov 2025$92.73$90.49$96.85
21 Nov 2025$98.27$91.41$96.12
28 Nov 2025$104.41$92.87$95.91
5 Dec 2025$100.79$94.58$95.64
12 Dec 2025$100.49$95.93$95.32
19 Dec 2025$96.24$96.38$94.96
26 Dec 2025$96.75$96.91$94.60
2 Jan 2026$98.15$97.10$94.31
9 Jan 2026$104.43$97.71$94.19
16 Jan 2026$112.50$99.49$94.30
23 Jan 2026$116.73$101.44$94.63
30 Jan 2026$108.80$103.29$95.02
6 Feb 2026$101.59$103.98$95.27
13 Feb 2026$96.03$103.59$95.41
20 Feb 2026$100.33$103.33$95.51
27 Feb 2026$98.31$103.00$95.63
6 Mar 2026$91.34$102.90$95.69
13 Mar 2026$85.57$102.03$95.63
20 Mar 2026$85.94$100.54$95.51
27 Mar 2026$83.90$98.58$95.36
2 Apr 2026$88.94$96.44$95.20
10 Apr 2026$89.79$93.87$95.05
17 Apr 2026$93.96$92.54$94.92
24 Apr 2026$86.77$91.45$94.69
1 May 2026$86.68$90.32$94.36
8 May 2026$101.00$90.04$94.37
15 May 2026$93.97$90.01$94.36
22 May 2026$96.95$90.62$94.56
29 May 2026$104.55$91.72$94.82
5 Jun 2026$98.37$93.09$95.07
12 Jun 2026$99.66$94.60$95.31
18 Jun 2026$100.00$95.49$95.53
26 Jun 2026$113.02$96.92$96.05
2 Jul 2026$113.76$98.49$96.62
10 Jul 2026$112.29$100.88$97.26
17 Jul 2026$110.15$103.30$97.93
24 Jul 2026$110.47$104.38$98.39
31 Jul 2026$112.52$106.02$98.92
7 Aug 2026$114.66$107.82$99.44
14 Aug 2026$116.84$109.34$99.93
21 Aug 2026$124.75$111.18$100.58
28 Aug 2026$128.80$113.82$101.46
4 Sep 2026$130.22$116.40$102.36
11 Sep 2026$124.31$117.35$102.96
18 Sep 2026$143.45$120.22$103.89
25 Sep 2026$151.11$123.69$105.00
2 Oct 2026$151.53$127.82$106.26
9 Oct 2026$154.18$132.09$107.69
16 Oct 2026$152.64$136.12$109.12
23 Oct 2026$158.77$140.08$110.49
30 Oct 2026$157.00$144.48$111.88
4 Nov 2026$159.43$146.52$112.56
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.

  • Price $159.43
  • 50-day avg $146.52
  • 200-day avg $112.56
Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023$88.16$106.28$120.40
10 Nov 2023$84.49$103.03$119.10
17 Nov 2023$87.97$100.60$117.82
24 Nov 2023$90.09$98.90$116.81
1 Dec 2023$91.28$96.72$115.61
8 Dec 2023$91.02$94.83$114.62
15 Dec 2023$101.16$93.66$113.90
22 Dec 2023$107.71$93.33$113.36
29 Dec 2023$109.31$93.75$113.13
5 Jan 2024$107.36$94.21$112.79
12 Jan 2024$110.80$96.05$112.39
19 Jan 2024$106.43$97.78$111.89
26 Jan 2024$110.00$100.11$111.26
2 Feb 2024$105.62$102.15$110.59
9 Feb 2024$103.76$103.62$109.86
16 Feb 2024$102.46$104.93$109.20
23 Feb 2024$104.44$105.94$108.68
1 Mar 2024$107.12$106.77$108.35
8 Mar 2024$109.33$106.95$108.13
15 Mar 2024$104.90$106.74$107.87
22 Mar 2024$103.25$106.23$107.60
28 Mar 2024$105.00$105.85$107.43
5 Apr 2024$102.28$105.42$107.08
12 Apr 2024$103.49$105.22$106.87
19 Apr 2024$100.86$104.77$106.44
26 Apr 2024$101.51$104.64$106.05
3 May 2024$100.61$104.55$105.53
10 May 2024$104.80$104.29$104.89
17 May 2024$110.23$104.28$104.45
24 May 2024$113.27$104.74$104.20
31 May 2024$109.26$105.16$104.02
7 Jun 2024$110.92$105.74$103.92
14 Jun 2024$108.65$106.47$103.75
21 Jun 2024$107.98$106.52$103.57
28 Jun 2024$104.86$106.75$103.48
5 Jul 2024$103.56$106.88$103.28
12 Jul 2024$109.52$107.30$103.21
19 Jul 2024$108.15$108.15$103.24
26 Jul 2024$115.15$108.87$103.35
2 Aug 2024$123.27$110.38$103.80
9 Aug 2024$118.75$111.07$104.21
16 Aug 2024$119.66$112.05$104.77
23 Aug 2024$121.25$113.01$105.67
30 Aug 2024$122.54$114.37$106.60
6 Sep 2024$115.41$115.29$107.18
13 Sep 2024$122.03$116.99$107.97
20 Sep 2024$122.89$118.80$108.82
27 Sep 2024$126.06$120.15$109.66
4 Oct 2024$123.96$121.59$110.33
11 Oct 2024$121.51$121.38$110.71
18 Oct 2024$119.67$121.54$111.01
25 Oct 2024$116.33$121.45$111.22
1 Nov 2024$121.04$121.36$111.49
8 Nov 2024$122.47$121.64$111.92
15 Nov 2024$109.52$121.51$112.11
22 Nov 2024$112.03$120.53$112.28
29 Nov 2024$116.14$119.84$112.52
6 Dec 2024$116.46$119.06$112.84
13 Dec 2024$115.94$118.25$113.11
20 Dec 2024$112.56$117.28$113.23
27 Dec 2024$111.99$116.49$113.30
3 Jan 2025$113.60$115.92$113.45
10 Jan 2025$113.88$115.80$113.69
17 Jan 2025$118.39$115.76$114.09
24 Jan 2025$123.15$115.68$114.49
31 Jan 2025$126.13$116.47$114.96
7 Feb 2025$118.86$117.54$115.49
14 Feb 2025$112.26$117.24$115.73
21 Feb 2025$113.84$117.10$115.97
28 Feb 2025$112.15$116.72$116.22
7 Mar 2025$117.56$116.72$116.34
14 Mar 2025$111.91$116.81$116.35
21 Mar 2025$107.29$116.43$116.36
28 Mar 2025$105.62$115.30$116.30
4 Apr 2025$94.84$113.39$116.11
11 Apr 2025$94.86$110.47$115.83
17 Apr 2025$91.82$108.14$115.63
25 Apr 2025$94.29$105.91$115.37
2 May 2025$93.99$103.98$114.99
9 May 2025$91.25$101.76$114.52
16 May 2025$93.26$100.03$113.91
23 May 2025$89.33$97.76$113.13
30 May 2025$90.42$96.13$112.60
6 Jun 2025$91.97$94.48$111.89
13 Jun 2025$93.53$93.37$111.26
20 Jun 2025$94.99$93.30$110.71
27 Jun 2025$97.82$93.37$110.20
3 Jul 2025$101.31$93.97$109.77
11 Jul 2025$101.50$94.58$109.19
18 Jul 2025$93.26$94.87$108.47
25 Jul 2025$103.67$95.29$107.80
1 Aug 2025$88.23$95.17$107.05
8 Aug 2025$86.84$94.83$106.20
15 Aug 2025$90.78$94.63$105.48
22 Aug 2025$94.15$94.41$104.78
29 Aug 2025$90.11$93.95$103.93
5 Sep 2025$86.64$93.14$103.26
12 Sep 2025$82.87$91.73$102.62
19 Sep 2025$86.72$90.24$101.89
26 Sep 2025$84.06$88.99$101.12
3 Oct 2025$94.05$88.34$100.43
10 Oct 2025$88.29$88.03$99.90
17 Oct 2025$93.42$88.51$99.40
24 Oct 2025$98.89$89.38$98.98
31 Oct 2025$93.59$89.78$98.38
7 Nov 2025$90.78$89.82$97.63
14 Nov 2025$92.73$90.49$96.85
21 Nov 2025$98.27$91.41$96.12
28 Nov 2025$104.41$92.87$95.91
5 Dec 2025$100.79$94.58$95.64
12 Dec 2025$100.49$95.93$95.32
19 Dec 2025$96.24$96.38$94.96
26 Dec 2025$96.75$96.91$94.60
2 Jan 2026$98.15$97.10$94.31
9 Jan 2026$104.43$97.71$94.19
16 Jan 2026$112.50$99.49$94.30
23 Jan 2026$116.73$101.44$94.63
30 Jan 2026$108.80$103.29$95.02
6 Feb 2026$101.59$103.98$95.27
13 Feb 2026$96.03$103.59$95.41
20 Feb 2026$100.33$103.33$95.51
27 Feb 2026$98.31$103.00$95.63
6 Mar 2026$91.34$102.90$95.69
13 Mar 2026$85.57$102.03$95.63
20 Mar 2026$85.94$100.54$95.51
27 Mar 2026$83.90$98.58$95.36
2 Apr 2026$88.94$96.44$95.20
10 Apr 2026$89.79$93.87$95.05
17 Apr 2026$93.96$92.54$94.92
24 Apr 2026$86.77$91.45$94.69
1 May 2026$86.68$90.32$94.36
8 May 2026$101.00$90.04$94.37
15 May 2026$93.97$90.01$94.36
22 May 2026$96.95$90.62$94.56
29 May 2026$104.55$91.72$94.82
5 Jun 2026$98.37$93.09$95.07
12 Jun 2026$99.66$94.60$95.31
18 Jun 2026$100.00$95.49$95.53
26 Jun 2026$113.02$96.92$96.05
2 Jul 2026$113.76$98.49$96.62
10 Jul 2026$112.29$100.88$97.26
17 Jul 2026$110.15$103.30$97.93
24 Jul 2026$110.47$104.38$98.39
31 Jul 2026$112.52$106.02$98.92
7 Aug 2026$114.66$107.82$99.44
14 Aug 2026$116.84$109.34$99.93
21 Aug 2026$124.75$111.18$100.58
28 Aug 2026$128.80$113.82$101.46
4 Sep 2026$130.22$116.40$102.36
11 Sep 2026$124.31$117.35$102.96
18 Sep 2026$143.45$120.22$103.89
25 Sep 2026$151.11$123.69$105.00
2 Oct 2026$151.53$127.82$106.26
9 Oct 2026$154.18$132.09$107.69
16 Oct 2026$152.64$136.12$109.12
23 Oct 2026$158.77$140.08$110.49
30 Oct 2026$157.00$144.48$111.88
4 Nov 2026$159.43$146.52$112.56
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.

  • Price $159.43
  • 50-day avg $146.52
  • 200-day avg $112.56
Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021$176.89$179.21$154.09
12 Nov 2021$183.59$177.37$155.45
26 Nov 2021$183.09$176.82$157.15
10 Dec 2021$187.78$177.60$159.58
23 Dec 2021$193.77$180.98$162.44
7 Jan 2022$181.65$184.43$165.68
21 Jan 2022$174.88$185.11$167.84
4 Feb 2022$182.95$183.33$169.88
18 Feb 2022$179.21$183.12$172.33
4 Mar 2022$176.43$181.36$173.98
18 Mar 2022$182.39$177.02$175.40
1 Apr 2022$171.57$176.78$177.07
14 Apr 2022$161.42$175.79$177.67
29 Apr 2022$146.61$169.57$177.59
13 May 2022$148.61$163.44$176.75
27 May 2022$156.18$158.50$174.86
10 Jun 2022$141.90$152.83$173.31
24 Jun 2022$145.53$147.48$171.14
8 Jul 2022$146.01$145.13$169.28
22 Jul 2022$146.67$143.47$167.41
5 Aug 2022$153.72$145.01$166.57
19 Aug 2022$145.13$146.03$165.45
2 Sep 2022$134.59$145.80$163.51
16 Sep 2022$130.14$144.23$161.35
30 Sep 2022$120.33$140.99$158.25
14 Oct 2022$120.12$135.29$154.84
28 Oct 2022$135.94$130.67$152.10
11 Nov 2022$143.46$129.19$150.04
25 Nov 2022$136.93$129.59$148.12
9 Dec 2022$139.15$132.43$146.06
23 Dec 2022$140.63$136.00$144.36
6 Jan 2023$133.53$137.73$142.95
20 Jan 2023$137.82$137.92$141.05
3 Feb 2023$141.75$138.25$139.71
17 Feb 2023$133.44$138.18$139.03
3 Mar 2023$131.34$135.57$138.14
17 Mar 2023$122.56$132.12$136.98
31 Mar 2023$133.26$130.88$136.07
14 Apr 2023$137.11$130.31$135.79
28 Apr 2023$130.49$129.00$135.24
12 May 2023$116.30$128.69$134.46
26 May 2023$116.67$127.22$132.58
9 Jun 2023$111.09$125.09$130.92
23 Jun 2023$115.97$122.04$129.98
7 Jul 2023$116.32$118.95$129.16
21 Jul 2023$130.87$117.70$129.18
4 Aug 2023$123.24$119.32$129.29
18 Aug 2023$113.22$119.87$128.59
1 Sep 2023$116.92$120.17$127.76
15 Sep 2023$113.44$119.04$126.57
29 Sep 2023$110.70$116.77$125.12
13 Oct 2023$105.85$112.90$123.43
27 Oct 2023$97.87$109.36$121.62
10 Nov 2023$84.49$103.03$119.10
24 Nov 2023$90.09$98.90$116.81
8 Dec 2023$91.02$94.83$114.62
22 Dec 2023$107.71$93.33$113.36
5 Jan 2024$107.36$94.21$112.79
19 Jan 2024$106.43$97.78$111.89
2 Feb 2024$105.62$102.15$110.59
16 Feb 2024$102.46$104.93$109.20
1 Mar 2024$107.12$106.77$108.35
15 Mar 2024$104.90$106.74$107.87
28 Mar 2024$105.00$105.85$107.43
12 Apr 2024$103.49$105.22$106.87
26 Apr 2024$101.51$104.64$106.05
10 May 2024$104.80$104.29$104.89
24 May 2024$113.27$104.74$104.20
7 Jun 2024$110.92$105.74$103.92
21 Jun 2024$107.98$106.52$103.57
5 Jul 2024$103.56$106.88$103.28
19 Jul 2024$108.15$108.15$103.24
2 Aug 2024$123.27$110.38$103.80
16 Aug 2024$119.66$112.05$104.77
30 Aug 2024$122.54$114.37$106.60
13 Sep 2024$122.03$116.99$107.97
27 Sep 2024$126.06$120.15$109.66
11 Oct 2024$121.51$121.38$110.71
25 Oct 2024$116.33$121.45$111.22
8 Nov 2024$122.47$121.64$111.92
22 Nov 2024$112.03$120.53$112.28
6 Dec 2024$116.46$119.06$112.84
20 Dec 2024$112.56$117.28$113.23
3 Jan 2025$113.60$115.92$113.45
17 Jan 2025$118.39$115.76$114.09
31 Jan 2025$126.13$116.47$114.96
14 Feb 2025$112.26$117.24$115.73
28 Feb 2025$112.15$116.72$116.22
14 Mar 2025$111.91$116.81$116.35
28 Mar 2025$105.62$115.30$116.30
11 Apr 2025$94.86$110.47$115.83
25 Apr 2025$94.29$105.91$115.37
9 May 2025$91.25$101.76$114.52
23 May 2025$89.33$97.76$113.13
6 Jun 2025$91.97$94.48$111.89
20 Jun 2025$94.99$93.30$110.71
3 Jul 2025$101.31$93.97$109.77
18 Jul 2025$93.26$94.87$108.47
1 Aug 2025$88.23$95.17$107.05
15 Aug 2025$90.78$94.63$105.48
29 Aug 2025$90.11$93.95$103.93
12 Sep 2025$82.87$91.73$102.62
26 Sep 2025$84.06$88.99$101.12
10 Oct 2025$88.29$88.03$99.90
24 Oct 2025$98.89$89.38$98.98
7 Nov 2025$90.78$89.82$97.63
21 Nov 2025$98.27$91.41$96.12
5 Dec 2025$100.79$94.58$95.64
19 Dec 2025$96.24$96.38$94.96
2 Jan 2026$98.15$97.10$94.31
16 Jan 2026$112.50$99.49$94.30
30 Jan 2026$108.80$103.29$95.02
13 Feb 2026$96.03$103.59$95.41
27 Feb 2026$98.31$103.00$95.63
13 Mar 2026$85.57$102.03$95.63
27 Mar 2026$83.90$98.58$95.36
10 Apr 2026$89.79$93.87$95.05
24 Apr 2026$86.77$91.45$94.69
8 May 2026$101.00$90.04$94.37
22 May 2026$96.95$90.62$94.56
5 Jun 2026$98.37$93.09$95.07
18 Jun 2026$100.00$95.49$95.53
2 Jul 2026$113.76$98.49$96.62
17 Jul 2026$110.15$103.30$97.93
31 Jul 2026$112.52$106.02$98.92
14 Aug 2026$116.84$109.34$99.93
28 Aug 2026$128.80$113.82$101.46
11 Sep 2026$124.31$117.35$102.96
25 Sep 2026$151.11$123.69$105.00
9 Oct 2026$154.18$132.09$107.69
23 Oct 2026$158.77$140.08$110.49
4 Nov 2026$159.43$146.52$112.56
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.

  • Price $159.43
  • 50-day avg $146.52
  • 200-day avg $112.56
Nov 2026: $159.43, 41.6% above its 200-day average. The price has been rising for 19 weeks.
WeekPrice50-day avg200-day avg
28 Oct 2016$50.80$53.86–
18 Nov 2016$49.95$52.84–
9 Dec 2016$53.56$52.10–
30 Dec 2016$52.15$51.78–
20 Jan 2017$51.71$52.21–
10 Feb 2017$53.97$52.74–
3 Mar 2017$54.94$53.40–
24 Mar 2017$57.52$54.38–
13 Apr 2017$56.95$55.84–
5 May 2017$61.60$57.26$54.31
26 May 2017$62.80$59.42$54.83
16 Jun 2017$63.57$61.22$55.49
7 Jul 2017$67.97$64.07$56.51
28 Jul 2017$65.89$66.24$57.49
18 Aug 2017$63.47$66.66$58.45
8 Sep 2017$67.65$66.64$59.53
29 Sep 2017$68.97$66.63$60.78
20 Oct 2017$71.73$68.04$62.12
10 Nov 2017$71.33$70.06$63.54
1 Dec 2017$73.12$71.31$64.89
22 Dec 2017$73.05$71.84$66.13
12 Jan 2018$78.89$72.93$67.34
2 Feb 2018$78.08$75.48$68.96
23 Feb 2018$77.02$76.40$70.04
16 Mar 2018$77.34$77.55$71.12
6 Apr 2018$73.20$76.61$71.88
27 Apr 2018$74.11$75.75$72.37
18 May 2018$75.47$75.08$72.81
8 Jun 2018$78.30$74.83$73.62
29 Jun 2018$73.23$75.02$74.28
20 Jul 2018$78.00$75.59$74.74
10 Aug 2018$84.92$77.71$75.57
31 Aug 2018$92.43$80.73$76.76
21 Sep 2018$96.61$86.65$78.33
12 Oct 2018$86.96$91.07$79.92
2 Nov 2018$83.62$91.00$80.55
23 Nov 2018$81.67$88.22$80.78
14 Dec 2018$83.73$85.20$81.46
4 Jan 2019$75.89$82.13$81.44
25 Jan 2019$86.49$81.71$81.98
15 Feb 2019$93.99$84.27$83.27
8 Mar 2019$91.87$87.69$84.65
29 Mar 2019$96.36$92.38$86.02
18 Apr 2019$94.15$95.20$87.65
10 May 2019$92.41$95.58$89.04
31 May 2019$86.34$93.43$89.29
21 Jun 2019$95.35$92.02$89.64
12 Jul 2019$95.18$92.14$89.72
2 Aug 2019$84.60$92.80$89.72
23 Aug 2019$80.76$90.68$89.47
13 Sep 2019$86.67$87.27$89.54
4 Oct 2019$85.44$84.20$89.54
25 Oct 2019$86.23$83.63$89.98
15 Nov 2019$90.95$85.25$90.11
6 Dec 2019$94.12$87.00$90.04
27 Dec 2019$97.05$90.62$90.17
17 Jan 2020$101.32$94.42$90.43
7 Feb 2020$93.07$96.58$90.38
28 Feb 2020$86.44$96.05$90.24
20 Mar 2020$70.89$89.79$89.47
9 Apr 2020$78.34$82.61$88.11
1 May 2020$89.09$79.69$87.26
22 May 2020$93.41$82.18$87.41
12 Jun 2020$97.14$90.39$88.78
2 Jul 2020$97.94$95.63$89.70
24 Jul 2020$110.37$100.59$91.36
14 Aug 2020$118.25$107.13$94.00
4 Sep 2020$114.30$112.54$96.21
25 Sep 2020$119.80$117.07$97.96
16 Oct 2020$124.02$120.08$100.16
6 Nov 2020$141.30$123.38$102.33
27 Nov 2020$129.26$126.84$104.71
18 Dec 2020$142.70$132.64$108.72
8 Jan 2021$159.76$138.17$113.56
29 Jan 2021$147.07$143.19$118.72
19 Feb 2021$136.79$146.60$122.82
12 Mar 2021$123.10$141.59$125.28
1 Apr 2021$129.88$134.91$127.12
23 Apr 2021$134.97$130.87$129.77
14 May 2021$143.56$131.28$131.74
4 Jun 2021$138.96$136.17$133.37
25 Jun 2021$152.43$141.29$135.73
16 Jul 2021$154.10$147.24$138.21
6 Aug 2021$185.43$156.56$141.78
27 Aug 2021$182.91$168.31$145.78
17 Sep 2021$187.56$177.61$149.74
8 Oct 2021$169.97$182.40$152.25
29 Oct 2021$176.89$179.21$154.09
19 Nov 2021$188.82$177.17$156.47
10 Dec 2021$187.78$177.60$159.58
31 Dec 2021$201.06$183.65$164.25
21 Jan 2022$174.88$185.11$167.84
11 Feb 2022$180.55$183.51$171.14
4 Mar 2022$176.43$181.36$173.98
25 Mar 2022$176.80$176.81$176.37
14 Apr 2022$161.42$175.79$177.67
6 May 2022$147.87$166.95$177.45
27 May 2022$156.18$158.50$174.86
17 Jun 2022$134.91$149.64$172.11
8 Jul 2022$146.01$145.13$169.28
29 Jul 2022$153.17$143.96$166.94
19 Aug 2022$145.13$146.03$165.45
9 Sep 2022$141.62$145.26$162.52
30 Sep 2022$120.33$140.99$158.25
21 Oct 2022$130.55$132.54$153.25
11 Nov 2022$143.46$129.19$150.04
2 Dec 2022$139.23$130.60$147.01
23 Dec 2022$140.63$136.00$144.36
13 Jan 2023$133.77$137.55$141.84
3 Feb 2023$141.75$138.25$139.71
24 Feb 2023$125.13$137.13$138.61
17 Mar 2023$122.56$132.12$136.98
6 Apr 2023$133.57$130.51$135.98
28 Apr 2023$130.49$129.00$135.24
19 May 2023$119.09$127.65$133.48
9 Jun 2023$111.09$125.09$130.92
30 Jun 2023$118.79$120.17$129.46
21 Jul 2023$130.87$117.70$129.18
11 Aug 2023$118.84$119.82$129.09
1 Sep 2023$116.92$120.17$127.76
22 Sep 2023$109.50$118.16$125.87
13 Oct 2023$105.85$112.90$123.43
3 Nov 2023$88.16$106.28$120.40
24 Nov 2023$90.09$98.90$116.81
15 Dec 2023$101.16$93.66$113.90
5 Jan 2024$107.36$94.21$112.79
26 Jan 2024$110.00$100.11$111.26
16 Feb 2024$102.46$104.93$109.20
8 Mar 2024$109.33$106.95$108.13
28 Mar 2024$105.00$105.85$107.43
19 Apr 2024$100.86$104.77$106.44
10 May 2024$104.80$104.29$104.89
31 May 2024$109.26$105.16$104.02
21 Jun 2024$107.98$106.52$103.57
12 Jul 2024$109.52$107.30$103.21
2 Aug 2024$123.27$110.38$103.80
23 Aug 2024$121.25$113.01$105.67
13 Sep 2024$122.03$116.99$107.97
4 Oct 2024$123.96$121.59$110.33
25 Oct 2024$116.33$121.45$111.22
15 Nov 2024$109.52$121.51$112.11
6 Dec 2024$116.46$119.06$112.84
27 Dec 2024$111.99$116.49$113.30
17 Jan 2025$118.39$115.76$114.09
7 Feb 2025$118.86$117.54$115.49
28 Feb 2025$112.15$116.72$116.22
21 Mar 2025$107.29$116.43$116.36
11 Apr 2025$94.86$110.47$115.83
2 May 2025$93.99$103.98$114.99
23 May 2025$89.33$97.76$113.13
13 Jun 2025$93.53$93.37$111.26
3 Jul 2025$101.31$93.97$109.77
25 Jul 2025$103.67$95.29$107.80
15 Aug 2025$90.78$94.63$105.48
5 Sep 2025$86.64$93.14$103.26
26 Sep 2025$84.06$88.99$101.12
17 Oct 2025$93.42$88.51$99.40
7 Nov 2025$90.78$89.82$97.63
28 Nov 2025$104.41$92.87$95.91
19 Dec 2025$96.24$96.38$94.96
9 Jan 2026$104.43$97.71$94.19
30 Jan 2026$108.80$103.29$95.02
20 Feb 2026$100.33$103.33$95.51
13 Mar 2026$85.57$102.03$95.63
2 Apr 2026$88.94$96.44$95.20
24 Apr 2026$86.77$91.45$94.69
15 May 2026$93.97$90.01$94.36
5 Jun 2026$98.37$93.09$95.07
26 Jun 2026$113.02$96.92$96.05
17 Jul 2026$110.15$103.30$97.93
7 Aug 2026$114.66$107.82$99.44
28 Aug 2026$128.80$113.82$101.46
18 Sep 2026$143.45$120.22$103.89
9 Oct 2026$154.18$132.09$107.69
30 Oct 2026$157.00$144.48$111.88
4 Nov 2026$159.43$146.52$112.56
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Falling from Oct 2025 to Nov 2025; Sideways from Nov 2025 to Feb 2026; Falling from Mar 2026 to May 2026; Sideways from May 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Falling from Nov 2023 to May 2024; Sideways from May 2024 to Sep 2024; Rising from Sep 2024 to Feb 2025; Sideways from Feb 2025 to Jun 2025; Falling from Jun 2025 to Nov 2025; Sideways from Nov 2025 to Feb 2026; Falling from Mar 2026 to May 2026; Sideways from May 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Rising from Oct 2021 to Mar 2022; Sideways from Apr 2022 to Aug 2022; Falling from Aug 2022 to May 2024; Sideways from May 2024 to Sep 2024; Rising from Sep 2024 to Jan 2025; Sideways from Feb 2025 to Jun 2025; Falling from Jun 2025 to Nov 2025; Sideways from Nov 2025 to Feb 2026; Falling from Mar 2026 to Apr 2026; Sideways from May 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Price stage: Rising from Dec 2017 to Jul 2019; Sideways from Aug 2019 to Dec 2019; Sideways from Dec 2019 to Jul 2020; Rising from Jul 2020 to Mar 2022; Sideways from Apr 2022 to Jul 2022; Falling from Aug 2022 to May 2024; Sideways from May 2024 to Feb 2025; Sideways from Feb 2025 to Jun 2025; Falling from Jul 2025 to Nov 2025; Sideways from Nov 2025 to Feb 2026; Falling from Mar 2026 to Jun 2026; Rising from Jul 2026 to Nov 2026.

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?

Ahead in 237 of 527 weeks

Week by week since 2016: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
8 Jul 2016no S&P 500 reading
15 Jul 2016no S&P 500 reading
22 Jul 2016no S&P 500 reading
29 Jul 2016no S&P 500 reading
5 Aug 2016no S&P 500 reading
12 Aug 2016no S&P 500 reading
19 Aug 2016no S&P 500 reading
26 Aug 2016no S&P 500 reading
2 Sep 2016no S&P 500 reading
9 Sep 2016no S&P 500 reading
16 Sep 2016no S&P 500 reading
23 Sep 2016no S&P 500 reading
30 Sep 2016no S&P 500 reading
7 Oct 2016+2.1%
14 Oct 2016−4.6%
21 Oct 2016−3.3%
28 Oct 2016−8.6%
4 Nov 2016−2.5%
11 Nov 2016−5.5%
18 Nov 2016−9.7%
25 Nov 2016−6.6%
2 Dec 2016−5.2%
9 Dec 2016−4.7%
16 Dec 2016−4.4%
23 Dec 2016−9.7%
30 Dec 2016−10.4%
6 Jan 2017−10.3%
13 Jan 2017−3.1%
20 Jan 2017−7.8%
27 Jan 2017−4.7%
3 Feb 2017−7.8%
10 Feb 2017−0.9%
17 Feb 2017+4.4%
24 Feb 2017−0.1%
3 Mar 2017−0.8%
10 Mar 2017−1.1%
17 Mar 2017+1.0%
24 Mar 2017+5.6%
31 Mar 2017+5.9%
7 Apr 2017+5.4%
13 Apr 2017+3.3%
21 Apr 2017+7.2%
28 Apr 2017+9.6%
5 May 2017+13.6%
12 May 2017+12.4%
19 May 2017+9.4%
26 May 2017+12.0%
2 Jun 2017+15.7%
9 Jun 2017+12.6%
16 Jun 2017+8.6%
23 Jun 2017+15.0%
30 Jun 2017+14.8%
7 Jul 2017+14.6%
14 Jul 2017+16.4%
21 Jul 2017+16.3%
28 Jul 2017+7.2%
4 Aug 2017+1.2%
11 Aug 2017+0.3%
18 Aug 2017+0.5%
25 Aug 2017+2.9%
1 Sep 2017+1.8%
8 Sep 2017+4.5%
15 Sep 2017+6.0%
22 Sep 2017−3.0%
29 Sep 2017−2.7%
6 Oct 2017−1.2%
13 Oct 2017−1.0%
20 Oct 2017−1.0%
27 Oct 2017+6.0%
3 Nov 2017+5.4%
10 Nov 2017+5.9%
17 Nov 2017+7.7%
24 Nov 2017+5.8%
1 Dec 2017+2.4%
8 Dec 2017−2.7%
15 Dec 2017−2.5%
22 Dec 2017−0.1%
29 Dec 2017−0.2%
5 Jan 2018+1.5%
12 Jan 2018+1.5%
19 Jan 2018+3.7%
26 Jan 2018+2.6%
2 Feb 2018+4.0%
9 Feb 2018+0.8%
16 Feb 2018−0.3%
23 Feb 2018−0.5%
2 Mar 2018+0.5%
9 Mar 2018+6.5%
16 Mar 2018+4.3%
23 Mar 2018+4.8%
29 Mar 2018+4.9%
6 Apr 2018+0.1%
13 Apr 2018−1.1%
20 Apr 2018−2.8%
27 Apr 2018−3.5%
4 May 2018−3.3%
11 May 2018−0.5%
18 May 2018−0.6%
25 May 2018−2.6%
1 Jun 2018−1.0%
8 Jun 2018−0.9%
15 Jun 2018−0.4%
22 Jun 2018−5.9%
29 Jun 2018−6.4%
6 Jul 2018−4.5%
13 Jul 2018−3.8%
20 Jul 2018−0.3%
27 Jul 2018−0.2%
3 Aug 2018+11.9%
10 Aug 2018+8.5%
17 Aug 2018+8.0%
24 Aug 2018+12.1%
31 Aug 2018+16.7%
7 Sep 2018+16.1%
14 Sep 2018+18.0%
21 Sep 2018+23.6%
28 Sep 2018+25.7%
5 Oct 2018+19.3%
12 Oct 2018+16.2%
19 Oct 2018+11.7%
26 Oct 2018+13.2%
2 Nov 2018+1.0%
9 Nov 2018+2.1%
16 Nov 2018+0.4%
23 Nov 2018+1.8%
30 Nov 2018−0.8%
7 Dec 2018−2.1%
14 Dec 2018−2.1%
21 Dec 2018−6.0%
28 Dec 2018−5.8%
4 Jan 2019−5.2%
11 Jan 2019+2.2%
18 Jan 2019+3.8%
25 Jan 2019+2.8%
1 Feb 2019+9.3%
8 Feb 2019+10.6%
15 Feb 2019+12.9%
22 Feb 2019+8.5%
1 Mar 2019+9.1%
8 Mar 2019+5.6%
15 Mar 2019+4.3%
22 Mar 2019+10.9%
29 Mar 2019+10.7%
5 Apr 2019+16.1%
12 Apr 2019+7.7%
18 Apr 2019+0.1%
26 Apr 2019−1.6%
3 May 2019−2.6%
10 May 2019−5.9%
17 May 2019−11.6%
24 May 2019−9.0%
31 May 2019−8.7%
7 Jun 2019−3.7%
14 Jun 2019−4.0%
21 Jun 2019−3.5%
28 Jun 2019−3.7%
5 Jul 2019−4.0%
12 Jul 2019−8.4%
19 Jul 2019−2.8%
26 Jul 2019−1.9%
2 Aug 2019−11.9%
9 Aug 2019−12.2%
16 Aug 2019−5.2%
23 Aug 2019−7.2%
30 Aug 2019−10.5%
6 Sep 2019−13.5%
13 Sep 2019−10.8%
20 Sep 2019−10.7%
27 Sep 2019−12.4%
4 Oct 2019−11.8%
11 Oct 2019−12.4%
18 Oct 2019−11.7%
25 Oct 2019−9.1%
1 Nov 2019−0.5%
8 Nov 2019+0.2%
15 Nov 2019+2.5%
22 Nov 2019+4.2%
29 Nov 2019+4.9%
6 Dec 2019+6.8%
13 Dec 2019+3.5%
20 Dec 2019+4.0%
27 Dec 2019+4.7%
3 Jan 2020+4.0%
10 Jan 2020+12.4%
17 Jan 2020+10.5%
24 Jan 2020+6.7%
31 Jan 2020−0.1%
7 Feb 2020−0.9%
14 Feb 2020−3.2%
21 Feb 2020−5.8%
28 Feb 2020−1.2%
6 Mar 2020−5.7%
13 Mar 2020−6.7%
20 Mar 2020+2.1%
27 Mar 2020−1.4%
3 Apr 2020−3.6%
9 Apr 2020−7.3%
17 Apr 2020−3.8%
24 Apr 2020+1.7%
1 May 2020+8.4%
8 May 2020+11.3%
15 May 2020+12.4%
22 May 2020+12.0%
29 May 2020+13.5%
5 Jun 2020+17.7%
12 Jun 2020+18.6%
19 Jun 2020+3.9%
26 Jun 2020+7.2%
2 Jul 2020+11.8%
10 Jul 2020+15.4%
17 Jul 2020+18.1%
24 Jul 2020+12.7%
31 Jul 2020+18.0%
7 Aug 2020+14.6%
14 Aug 2020+9.7%
21 Aug 2020+10.2%
28 Aug 2020+1.2%
4 Sep 2020+2.2%
11 Sep 2020+11.3%
18 Sep 2020+13.0%
25 Sep 2020+18.0%
2 Oct 2020+20.3%
9 Oct 2020+18.6%
16 Oct 2020+5.9%
23 Oct 2020+5.0%
30 Oct 2020+8.9%
6 Nov 2020+13.8%
13 Nov 2020+5.4%
20 Nov 2020+6.7%
27 Nov 2020+6.8%
4 Dec 2020+16.1%
11 Dec 2020+14.5%
18 Dec 2020+9.1%
24 Dec 2020+4.4%
31 Dec 2020+3.2%
8 Jan 2021+13.3%
15 Jan 2021+11.6%
22 Jan 2021+11.3%
29 Jan 2021+0.2%
5 Feb 2021−8.1%
12 Feb 2021+4.3%
19 Feb 2021−4.7%
26 Feb 2021−7.0%
5 Mar 2021−16.2%
12 Mar 2021−23.3%
19 Mar 2021−15.5%
26 Mar 2021−14.6%
1 Apr 2021−16.6%
9 Apr 2021−24.4%
16 Apr 2021−21.4%
23 Apr 2021−20.0%
30 Apr 2021−24.6%
7 May 2021−11.7%
14 May 2021−10.8%
21 May 2021−0.6%
28 May 2021+4.6%
4 Jun 2021+1.9%
11 Jun 2021+11.6%
18 Jun 2021+10.8%
25 Jun 2021+9.9%
2 Jul 2021+11.5%
9 Jul 2021+9.6%
16 Jul 2021+12.4%
23 Jul 2021+16.2%
30 Jul 2021+35.5%
6 Aug 2021+26.7%
13 Aug 2021+20.5%
20 Aug 2021+18.2%
27 Aug 2021+18.9%
3 Sep 2021+29.9%
10 Sep 2021+22.4%
17 Sep 2021+18.1%
24 Sep 2021+15.9%
1 Oct 2021+11.5%
8 Oct 2021+9.9%
15 Oct 2021+6.8%
22 Oct 2021+4.3%
29 Oct 2021−7.7%
5 Nov 2021−14.8%
12 Nov 2021−4.5%
19 Nov 2021−1.5%
26 Nov 2021−1.8%
3 Dec 2021−3.9%
10 Dec 2021−5.3%
17 Dec 2021−4.2%
23 Dec 2021−0.1%
31 Dec 2021+6.4%
7 Jan 2022+0.4%
14 Jan 2022+0.9%
21 Jan 2022+2.5%
28 Jan 2022−0.5%
4 Feb 2022+12.6%
11 Feb 2022+4.1%
18 Feb 2022+2.3%
25 Feb 2022+4.7%
4 Mar 2022+1.0%
11 Mar 2022−0.9%
18 Mar 2022+0.6%
25 Mar 2022−5.0%
1 Apr 2022−10.0%
8 Apr 2022−1.1%
14 Apr 2022−3.8%
22 Apr 2022−10.0%
29 Apr 2022−6.7%
6 May 2022−10.8%
13 May 2022−8.9%
20 May 2022−7.9%
27 May 2022−9.6%
3 Jun 2022−11.3%
10 Jun 2022−7.3%
17 Jun 2022−8.3%
24 Jun 2022−3.9%
1 Jul 2022−0.2%
8 Jul 2022−2.2%
15 Jul 2022−4.2%
22 Jul 2022+3.4%
29 Jul 2022+4.5%
5 Aug 2022+3.4%
12 Aug 2022−0.1%
19 Aug 2022−9.4%
26 Aug 2022−9.5%
2 Sep 2022−4.4%
9 Sep 2022−4.5%
16 Sep 2022−8.9%
23 Sep 2022−10.3%
30 Sep 2022−10.2%
7 Oct 2022−8.4%
14 Oct 2022−4.0%
21 Oct 2022−5.7%
28 Oct 2022−5.7%
4 Nov 2022−6.1%
11 Nov 2022−2.5%
18 Nov 2022+0.0%
25 Nov 2022+0.3%
2 Dec 2022−0.3%
9 Dec 2022+1.5%
16 Dec 2022+6.4%
23 Dec 2022+10.9%
30 Dec 2022+9.5%
6 Jan 2023+0.7%
13 Jan 2023−0.1%
20 Jan 2023−0.2%
27 Jan 2023−2.4%
3 Feb 2023−0.9%
10 Feb 2023−7.8%
17 Feb 2023−4.8%
24 Feb 2023−7.1%
3 Mar 2023−5.0%
10 Mar 2023−11.7%
17 Mar 2023−12.7%
24 Mar 2023−12.6%
31 Mar 2023−12.0%
6 Apr 2023−5.4%
14 Apr 2023−1.0%
21 Apr 2023−7.7%
28 Apr 2023−8.4%
5 May 2023−8.4%
12 May 2023−15.2%
19 May 2023−13.5%
26 May 2023−12.7%
2 Jun 2023−18.1%
9 Jun 2023−19.0%
16 Jun 2023−15.4%
23 Jun 2023−18.6%
30 Jun 2023−19.1%
7 Jul 2023−20.1%
14 Jul 2023−19.4%
21 Jul 2023−11.3%
28 Jul 2023−13.2%
4 Aug 2023−13.4%
11 Aug 2023−6.1%
18 Aug 2023−9.2%
25 Aug 2023−6.2%
1 Sep 2023−4.0%
8 Sep 2023−7.5%
15 Sep 2023−5.8%
22 Sep 2023−4.9%
29 Sep 2023−3.2%
6 Oct 2023−5.5%
13 Oct 2023−9.9%
20 Oct 2023−15.5%
27 Oct 2023−12.3%
3 Nov 2023−25.8%
10 Nov 2023−27.8%
17 Nov 2023−25.6%
24 Nov 2023−25.1%
1 Dec 2023−23.7%
8 Dec 2023−18.1%
15 Dec 2023−16.7%
22 Dec 2023−11.7%
29 Dec 2023−12.4%
5 Jan 2024−9.1%
12 Jan 2024−5.8%
19 Jan 2024−9.9%
26 Jan 2024−6.3%
2 Feb 2024+6.1%
9 Feb 2024+9.1%
16 Feb 2024+5.7%
23 Feb 2024+4.4%
1 Mar 2024+5.6%
8 Mar 2024+8.9%
15 Mar 2024−4.9%
22 Mar 2024−14.2%
28 Mar 2024−14.0%
5 Apr 2024−15.5%
12 Apr 2024−13.8%
19 Apr 2024−7.9%
26 Apr 2024−12.0%
3 May 2024−8.2%
10 May 2024−2.9%
17 May 2024+1.6%
24 May 2024+4.2%
31 May 2024−0.8%
7 Jun 2024−2.9%
14 Jun 2024−2.9%
21 Jun 2024+0.1%
28 Jun 2024−4.2%
5 Jul 2024−5.7%
12 Jul 2024−3.8%
19 Jul 2024−3.6%
26 Jul 2024+6.3%
2 Aug 2024+18.3%
9 Aug 2024+11.0%
16 Aug 2024+3.9%
23 Aug 2024+0.9%
30 Aug 2024+5.3%
6 Sep 2024+2.9%
13 Sep 2024+8.8%
20 Sep 2024+9.4%
27 Sep 2024+15.2%
4 Oct 2024+16.4%
11 Oct 2024+7.4%
18 Oct 2024+4.2%
25 Oct 2024−5.3%
1 Nov 2024−9.0%
8 Nov 2024−9.1%
15 Nov 2024−14.1%
22 Nov 2024−13.5%
29 Nov 2024−12.1%
6 Dec 2024−11.6%
13 Dec 2024−12.5%
20 Dec 2024−12.4%
27 Dec 2024−15.3%
3 Jan 2025−11.7%
10 Jan 2025−6.4%
17 Jan 2025−3.3%
24 Jan 2025+0.9%
31 Jan 2025−1.2%
7 Feb 2025−3.4%
14 Feb 2025−1.6%
21 Feb 2025+0.9%
28 Feb 2025−2.0%
7 Mar 2025+6.2%
14 Mar 2025+3.4%
21 Mar 2025−0.1%
28 Mar 2025+0.9%
4 Apr 2025−1.9%
11 Apr 2025−8.7%
17 Apr 2025−10.5%
25 Apr 2025−14.0%
2 May 2025−19.7%
9 May 2025−17.2%
16 May 2025−14.4%
23 May 2025−18.1%
30 May 2025−18.6%
6 Jun 2025−25.8%
13 Jun 2025−22.5%
20 Jun 2025−16.8%
27 Jun 2025−18.0%
3 Jul 2025−16.9%
11 Jul 2025−9.8%
18 Jul 2025−17.7%
25 Jul 2025−5.8%
1 Aug 2025−15.8%
8 Aug 2025−17.7%
15 Aug 2025−10.9%
22 Aug 2025−6.0%
29 Aug 2025−9.8%
5 Sep 2025−13.8%
12 Sep 2025−21.5%
19 Sep 2025−20.4%
26 Sep 2025−21.7%
3 Oct 2025−14.2%
10 Oct 2025−17.7%
17 Oct 2025−5.7%
24 Oct 2025−10.9%
31 Oct 2025−3.6%
7 Nov 2025−0.8%
14 Nov 2025−2.3%
21 Nov 2025+2.2%
28 Nov 2025+9.9%
5 Dec 2025+10.4%
12 Dec 2025+17.6%
19 Dec 2025+8.4%
26 Dec 2025+10.8%
2 Jan 2026+2.3%
9 Jan 2026+12.0%
16 Jan 2026+16.3%
23 Jan 2026+16.3%
30 Jan 2026+14.8%
6 Feb 2026+9.0%
13 Feb 2026+2.1%
20 Feb 2026−2.5%
27 Feb 2026−6.2%
6 Mar 2026−7.4%
13 Mar 2026−12.0%
20 Mar 2026−6.0%
27 Mar 2026−5.1%
2 Apr 2026−5.4%
10 Apr 2026−11.9%
17 Apr 2026−19.2%
24 Apr 2026−29.3%
1 May 2026−24.5%
8 May 2026−7.4%
15 May 2026−10.6%
22 May 2026−11.5%
29 May 2026−3.9%
5 Jun 2026−2.0%
12 Jun 2026+4.5%
18 Jun 2026+1.2%
26 Jun 2026+19.7%
2 Jul 2026+14.3%
10 Jul 2026+13.9%
17 Jul 2026+12.6%
24 Jul 2026+23.8%
31 Jul 2026+26.2%
7 Aug 2026+8.7%
14 Aug 2026+19.3%
21 Aug 2026+26.0%
28 Aug 2026+21.5%
4 Sep 2026+28.0%
11 Sep 2026+21.7%
18 Sep 2026+41.4%
25 Sep 2026+27.9%
2 Oct 2026+29.9%
9 Oct 2026+34.2%
16 Oct 2026+35.9%
23 Oct 2026+40.9%
30 Oct 2026+38.4%
4 Nov 2026+39.9%
Each bar is one week, from 2016 to now (527 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 10 years the share price moved +196% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Revvity pay?

Revvity, Inc. paid $0.28 per share over the last four reported quarters. The most recent declaration was $0.07 for Jul 2026. At today's price of $159.43 that is a yield of 0.18%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.07 (Jul 2026)

  • Dividend per share $0.07
Dividend per share each quarter: latest $0.07 (Jul 2026)
QuarterDividend per share
Oct 2023$0.07
Dec 2023$0.07
Mar 2024$0.07
Jun 2024$0.07
Sep 2024$0.07
Dec 2024$0.07
Mar 2025$0.07
Jun 2025$0.07
Sep 2025$0.07
Dec 2025$0.07
Apr 2026$0.07
Jul 2026$0.07
Declared dividend per share, $ a share, each reported quarter. 12 quarters on file.

Which stock lists is Revvity on?

Revvity is on one of our US lists: S&P 500 companies.

Is Revvity profitable?

Revvity, Inc. earned $51.8 M of net profit in the Jul 2026 quarter, −3.9% on the same quarter a year earlier. Full-year FY25 profit was $241 M. Over 3 years profit has grown −36.5% a year on average. That is 7.1% of the quarter's revenue. The same quarter a year earlier earned $53.9 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY25 profit was $241 M (−10.8% on the year before).

FY25 profit $241 M (−10.8% on the year before), −36.5% a year over 3 years

  • Net profit $241 M
FY25 profit $241 M (−10.8% on the year before), −36.5% a year over 3 years
QuarterNet profit
FY22$943 M
FY23$569 M
FY23$693 M
FY24$270 M
FY25$241 M

Growth on a year earlier

  • Growth on a year earlier −10.8%
Growth on a year earlier
QuarterGrowth on a year earlier
FY22–
FY23−39.7%
FY2321.8%
FY24−61%
FY25−10.8%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jul 2026: $51.8 M (−3.9% on a year earlier)

  • Net profit (quarterly) $51.8 M
Jul 2026: $51.8 M (−3.9% on a year earlier)
QuarterNet profit (quarterly)
Oct 2023$9.5 M
Dec 2023$78.6 M
Mar 2024$26.0 M
Jun 2024$55.4 M
Sep 2024$94.4 M
Dec 2024$94.6 M
Mar 2025$42.2 M
Jun 2025$53.9 M
Sep 2025$46.7 M
Dec 2025$98.4 M
Apr 2026$40.7 M
Jul 2026$51.8 M

Growth on a year earlier

  • Growth on a year earlier −3.9%
Growth on a year earlier
QuarterGrowth on a year earlier
Oct 2023−88.9%
Dec 2023–
Mar 2024−95.4%
Jun 202455.7%
Sep 2024893.7%
Dec 202420.5%
Mar 202562.4%
Jun 2025−2.6%
Sep 2025−50.6%
Dec 20253.9%
Apr 2026−3.6%
Jul 2026−3.9%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +1.3% on a year earlier and the margin moved +2.8 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed −13.6% and revenue +4.1%. Profit is growing slower than sales: rising costs are taking part of the growth.

How much revenue does Revvity make, and is it growing?

Revvity, Inc. reported $730 M of revenue in the Jul 2026 quarter, +1.3% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 3 years it has grown −9.3% a year on average. The last full year, FY25, came in at $2.9 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $2.9 B.

FY25 revenue was $2.9 B, +3.7% on the year before.

FY25 revenue $2.9 B (+3.7% on the year before), −9.3% a year over 3 years

  • Revenue $2.9 B
FY25 revenue $2.9 B (+3.7% on the year before), −9.3% a year over 3 years
QuarterRevenue
FY22$3.8 B
FY23$3.3 B
FY23$2.8 B
FY24$2.8 B
FY25$2.9 B

Growth on a year earlier

  • Growth on a year earlier 3.7%
Growth on a year earlier
QuarterGrowth on a year earlier
FY22–
FY23−13.5%
FY23−16.9%
FY240.2%
FY253.7%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jul 2026: $730 M (+1.3% on a year earlier), the 8th quarter in a row of growth

  • Revenue (quarterly) $730 M
Jul 2026: $730 M (+1.3% on a year earlier), the 8th quarter in a row of growth
QuarterRevenue (quarterly)
Oct 2023$671 M
Dec 2023$696 M
Mar 2024$650 M
Jun 2024$692 M
Sep 2024$684 M
Dec 2024$729 M
Mar 2025$665 M
Jun 2025$720 M
Sep 2025$699 M
Dec 2025$772 M
Apr 2026$711 M
Jul 2026$730 M

Growth on a year earlier

  • Growth on a year earlier 1.3%
Growth on a year earlier
QuarterGrowth on a year earlier
Oct 2023−5.8%
Dec 2023–
Mar 2024−3.7%
Jun 2024−2.5%
Sep 20242%
Dec 20244.8%
Mar 20252.3%
Jun 20254.1%
Sep 20252.2%
Dec 20255.9%
Apr 20267%
Jul 20261.3%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +4.1% on average, against −9.3% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +4.1%, against +3.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −16.7%, against +18.4% a year (rolling over).

How much of every $100 of sales does Revvity keep?

Revvity, Inc.'s operating margin was 17.1% in the Jul 2026 quarter, 2.8 percentage points higher than the same quarter a year ago. Across 5 years it has been between 13.9% and 37.0%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +2.8 percentage points on the year while gross margin changed +2.6 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY25: 15.3%, within a range of 13.9% to 37.0% over 5 years

  • Operating margin 15.3%
FY25: 15.3%, within a range of 13.9% to 37.0% over 5 years
QuarterOperating margin
FY2237%
FY2325%
FY2313.9%
FY2414.9%
FY2515.3%

Change on the year before (points)

  • Change on the year before (points) +0.4 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY22–
FY23−12.0 pts
FY23−11.1 pts
FY24+1.0 pts
FY25+0.4 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jul 2026: operating margin 17.1% (+2.8 points on a year earlier)

  • Operating margin 17.1%
Jul 2026: operating margin 17.1% (+2.8 points on a year earlier)
QuarterOperating margin
Oct 202313.8%
Dec 202312.4%
Mar 202411.2%
Jun 202415.1%
Sep 202414.8%
Dec 202418.7%
Mar 202512.2%
Jun 202514.3%
Sep 202513.8%
Dec 202520.1%
Apr 202612.4%
Jul 202617.1%

Change on a year earlier (points)

  • Change on a year earlier (points) +2.8 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Oct 2023−5.1 pts
Dec 2023–
Mar 2024−3.0 pts
Jun 2024−0.1 pts
Sep 2024+1.0 pts
Dec 2024+6.3 pts
Mar 2025+1.0 pts
Jun 2025−0.8 pts
Sep 2025−1.0 pts
Dec 2025+1.4 pts
Apr 2026+0.2 pts
Jul 2026+2.8 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Revvity's profit turning into cash?

Over the last 3 years, 108% of Revvity, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $583 M of operating cash against $241 M of profit. After $73.5 M of spending on assets, $509 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $583 M against profit $241 M; 108% of 3 years' profit came in as cash

  • Operating cash $583 M
  • Net profit $241 M
  • Free cash $509 M
FY25: operating cash $583 M against profit $241 M; 108% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY22$1.4 B$943 M$1.3 B
FY23$680 M$569 M$594 M
FY23$91.3 M$693 M$9.9 M
FY24$628 M$270 M$542 M
FY25$583 M$241 M$509 M
Operating cash flow and net profit each year, $ B. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jul 2026: operating cash $192 M = 370% of the quarter's profit

  • Operating cash (quarterly) $192 M
Jul 2026: operating cash $192 M = 370% of the quarter's profit
QuarterOperating cash (quarterly)
Oct 2023−$33.5 M
Dec 2023$197 M
Mar 2024$148 M
Jun 2024$159 M
Sep 2024$148 M
Dec 2024$174 M
Mar 2025$128 M
Jun 2025$134 M
Sep 2025$139 M
Dec 2025$182 M
Apr 2026$115 M
Jul 2026$192 M

Operating cash as % of profit

  • Operating cash as % of profit 370%
Operating cash as % of profit
QuarterOperating cash as % of profit
Oct 2023−353%
Dec 2023250%
Mar 2024567%
Jun 2024287%
Sep 2024157%
Dec 2024184%
Mar 2025303%
Jun 2025249%
Sep 2025297%
Dec 2025185%
Apr 2026283%
Jul 2026370%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Revvity's cash go?

Revvity, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $242 M on assets over the last 3 years. Averaged over those years that is 2.8% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $242 M over the last 3 years.

FY25: capex $73.5 M, steady spending

  • Capex $73.5 M
FY25: capex $73.5 M, steady spending
QuarterCapex
FY22$86.0 M
FY23$85.6 M
FY23$81.4 M
FY24$86.6 M
FY25$73.5 M
Capital spending each year, $ M.

Jul 2026: capex $11.1 M in the quarter

  • Capex (quarterly) $11.1 M
Jul 2026: capex $11.1 M in the quarter
QuarterCapex (quarterly)
Oct 2023$22.4 M
Dec 2023$24.1 M
Mar 2024$17.8 M
Jun 2024$22.0 M
Sep 2024$22.3 M
Dec 2024$24.5 M
Mar 2025$16.0 M
Jun 2025$18.9 M
Sep 2025$18.5 M
Dec 2025$20.2 M
Apr 2026$19.8 M
Jul 2026$11.1 M

Free cash

  • Free cash $181 M
Free cash
QuarterFree cash
Oct 2023−$55.8 M
Dec 2023$172 M
Mar 2024$130 M
Jun 2024$137 M
Sep 2024$126 M
Dec 2024$150 M
Mar 2025$112 M
Jun 2025$115 M
Sep 2025$120 M
Dec 2025$162 M
Apr 2026$95.5 M
Jul 2026$181 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Revvity's P/E ratio, and how does it compare with its own history?

Revvity, Inc.'s P/E is 70.6×, near the high end of its own history: higher than 86% of past readings. Its usual P/E (the middle reading) is 40.0×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 70.6× against a usual 40.0×: near the high end of its own history: higher than 86% of past readings

  • P/E 75.9×
  • Median 40.0×
P/E 70.6× against a usual 40.0×: near the high end of its own history: higher than 86% of past readings
WeekP/EMedian
8 Apr 202233.8×40.0×
14 Apr 202231.7×40.0×
22 Apr 202229.9×40.0×
29 Apr 202228.8×40.0×
6 May 202229.0×40.0×
13 May 202229.1×40.0×
20 May 202228.8×40.0×
27 May 202230.6×40.0×
3 Jun 202229.0×40.0×
10 Jun 202227.8×40.0×
17 Jun 202226.5×40.0×
24 Jun 202228.6×40.0×
1 Jul 202228.3×40.0×
8 Jul 202226.9×40.0×
15 Jul 202224.9×40.0×
22 Jul 202227.1×40.0×
29 Jul 202228.3×40.0×
5 Aug 202228.4×40.0×
12 Aug 202229.1×40.0×
19 Aug 202226.8×40.0×
26 Aug 202225.4×40.0×
2 Sep 202224.8×40.0×
9 Sep 202226.1×40.0×
16 Sep 202224.0×40.0×
23 Sep 202222.6×40.0×
30 Sep 202222.2×40.0×
7 Oct 202224.9×40.0×
14 Oct 202224.1×40.0×
21 Oct 202226.2×40.0×
28 Oct 202227.3×40.0×
4 Nov 202226.2×40.0×
11 Nov 202228.8×40.0×
18 Nov 202227.3×40.0×
25 Nov 202227.5×40.0×
2 Dec 202227.9×40.0×
9 Dec 202227.9×40.0×
16 Dec 202227.6×40.0×
23 Dec 202228.2×40.0×
30 Dec 202228.1×40.0×
6 Jan 202329.7×40.0×
13 Jan 202329.7×40.0×
20 Jan 202330.6×40.0×
27 Jan 202330.8×40.0×
3 Feb 202331.5×40.0×
10 Feb 202330.2×40.0×
17 Feb 202329.7×40.0×
24 Feb 202327.8×40.0×
3 Mar 202329.2×40.0×
10 Mar 202326.7×40.0×
17 Mar 202327.3×40.0×
24 Mar 202328.4×40.0×
31 Mar 202329.6×40.0×
6 Apr 202317.5×40.0×
14 Apr 202318.0×40.0×
21 Apr 202317.5×40.0×
28 Apr 202317.1×40.0×
5 May 202317.1×40.0×
12 May 202315.3×40.0×
19 May 202315.6×40.0×
26 May 202315.3×40.0×
2 Jun 202315.1×40.0×
9 Jun 202314.6×40.0×
16 Jun 202315.7×40.0×
23 Jun 202315.2×40.0×
30 Jun 202315.6×40.0×
7 Jul 202318.0×40.0×
14 Jul 202319.0×40.0×
21 Jul 202320.2×40.0×
28 Jul 202319.5×40.0×
4 Aug 202319.0×40.0×
11 Aug 202318.4×40.0×
18 Aug 202317.5×40.0×
25 Aug 202317.7×40.0×
1 Sep 202318.1×40.0×
8 Sep 202316.5×40.0×
15 Sep 202317.5×40.0×
22 Sep 202316.9×40.0×
29 Sep 202317.1×40.0×
6 Oct 202318.3×40.0×
13 Oct 202318.0×40.0×
20 Oct 202317.3×40.0×
27 Oct 202316.6×40.0×
3 Nov 202315.0×40.0×
10 Nov 202314.4×40.0×
17 Nov 202315.0×40.0×
24 Nov 202315.3×40.0×
1 Dec 202315.5×40.0×
8 Dec 202315.5×40.0×
15 Dec 202317.2×40.0×
22 Dec 202318.3×40.0×
29 Dec 202318.6×40.0×
5 Jan 202419.5×40.0×
12 Jan 202420.1×40.0×
19 Jan 202419.3×40.0×
26 Jan 202420.0×40.0×
2 Feb 202419.2×40.0×
9 Feb 202418.9×40.0×
16 Feb 202418.6×40.0×
23 Feb 202419.0×40.0×
1 Mar 202419.5×40.0×
8 Mar 202419.9×40.0×
15 Mar 202419.1×40.0×
22 Mar 202418.8×40.0×
28 Mar 202419.1×40.0×
5 Apr 202485.2×40.0×
12 Apr 202486.2×40.0×
19 Apr 202484.0×40.0×
26 Apr 202484.5×40.0×
3 May 202483.8×40.0×
10 May 202487.3×40.0×
17 May 202491.0×40.0×
24 May 202491.0×40.0×
31 May 202491.0×40.0×
7 Jun 202491.0×40.0×
14 Jun 202490.5×40.0×
21 Jun 202489.9×40.0×
28 Jun 202487.3×40.0×
5 Jul 202475.9×40.0×
12 Jul 202480.2×40.0×
19 Jul 202479.2×40.0×
26 Jul 202484.4×40.0×
2 Aug 202490.3×40.0×
9 Aug 202487.0×40.0×
16 Aug 202487.7×40.0×
23 Aug 202488.8×40.0×
30 Aug 202489.8×40.0×
6 Sep 202484.5×40.0×
13 Sep 202489.4×40.0×
20 Sep 202490.0×40.0×
27 Sep 202491.0×40.0×
4 Oct 202460.2×40.0×
11 Oct 202459.0×40.0×
18 Oct 202458.1×40.0×
25 Oct 202456.5×40.0×
1 Nov 202458.8×40.0×
8 Nov 202459.5×40.0×
15 Nov 202453.2×40.0×
22 Nov 202454.4×40.0×
29 Nov 202456.4×40.0×
6 Dec 202456.6×40.0×
13 Dec 202456.3×40.0×
20 Dec 202454.7×40.0×
27 Dec 202454.4×40.0×
3 Jan 202551.7×40.0×
10 Jan 202551.8×40.0×
17 Jan 202553.9×40.0×
24 Jan 202556.0×40.0×
31 Jan 202557.4×40.0×
7 Feb 202554.1×40.0×
14 Feb 202551.1×40.0×
21 Feb 202551.8×40.0×
28 Feb 202551.0×40.0×
7 Mar 202553.5×40.0×
14 Mar 202550.9×40.0×
21 Mar 202548.8×40.0×
28 Mar 202548.1×40.0×
4 Apr 202540.5×40.0×
11 Apr 202540.5×40.0×
17 Apr 202539.2×40.0×
25 Apr 202540.3×40.0×
2 May 202540.1×40.0×
9 May 202539.0×40.0×
16 May 202539.8×40.0×
23 May 202538.2×40.0×
30 May 202538.6×40.0×
6 Jun 202539.3×40.0×
13 Jun 202540.0×40.0×
20 Jun 202540.6×40.0×
27 Jun 202541.8×40.0×
3 Jul 202543.1×40.0×
11 Jul 202543.2×40.0×
18 Jul 202539.7×40.0×
25 Jul 202544.1×40.0×
1 Aug 202537.5×40.0×
8 Aug 202536.9×40.0×
15 Aug 202538.6×40.0×
22 Aug 202540.0×40.0×
29 Aug 202538.3×40.0×
5 Sep 202536.9×40.0×
12 Sep 202535.3×40.0×
19 Sep 202536.9×40.0×
26 Sep 202535.8×40.0×
3 Oct 202547.3×40.0×
10 Oct 202544.4×40.0×
17 Oct 202547.0×40.0×
24 Oct 202549.8×40.0×
31 Oct 202547.1×40.0×
7 Nov 202545.7×40.0×
14 Nov 202546.7×40.0×
21 Nov 202549.5×40.0×
28 Nov 202552.5×40.0×
5 Dec 202550.7×40.0×
12 Dec 202550.6×40.0×
19 Dec 202548.4×40.0×
26 Dec 202548.7×40.0×
2 Jan 202647.1×40.0×
9 Jan 202650.1×40.0×
16 Jan 202654.0×40.0×
23 Jan 202656.0×40.0×
30 Jan 202652.2×40.0×
6 Feb 202648.8×40.0×
13 Feb 202646.1×40.0×
20 Feb 202648.1×40.0×
27 Feb 202647.2×40.0×
6 Mar 202643.8×40.0×
13 Mar 202641.1×40.0×
20 Mar 202641.2×40.0×
27 Mar 202640.3×40.0×
2 Apr 202642.7×40.0×
10 Apr 202642.8×40.0×
17 Apr 202644.8×40.0×
24 Apr 202641.4×40.0×
1 May 202641.4×40.0×
8 May 202648.2×40.0×
15 May 202644.8×40.0×
22 May 202646.3×40.0×
29 May 202649.9×40.0×
5 Jun 202646.9×40.0×
12 Jun 202647.5×40.0×
18 Jun 202647.7×40.0×
26 Jun 202653.9×40.0×
2 Jul 202654.3×40.0×
10 Jul 202653.5×40.0×
17 Jul 202652.4×40.0×
24 Jul 202652.6×40.0×
31 Jul 202653.6×40.0×
7 Aug 202654.6×40.0×
14 Aug 202655.6×40.0×
21 Aug 202659.4×40.0×
28 Aug 202661.3×40.0×
4 Sep 202662.0×40.0×
11 Sep 202659.2×40.0×
18 Sep 202668.3×40.0×
25 Sep 202671.9×40.0×
2 Oct 202672.1×40.0×
9 Oct 202673.4×40.0×
16 Oct 202672.7×40.0×
23 Oct 202675.6×40.0×
30 Oct 202674.7×40.0×
4 Nov 202675.9×40.0×

Earnings per share, 12 months

  • Earnings per share, 12 months $2.10
Earnings per share, 12 months
WeekEarnings per share, 12 months
8 Apr 2022–
14 Apr 2022–
22 Apr 2022–
29 Apr 2022–
6 May 2022–
13 May 2022–
20 May 2022–
27 May 2022–
3 Jun 2022–
10 Jun 2022–
17 Jun 2022–
24 Jun 2022$5.10
1 Jul 2022$5.10
8 Jul 2022$5.10
15 Jul 2022$5.10
22 Jul 2022$5.10
29 Jul 2022$5.10
5 Aug 2022$5.10
12 Aug 2022$5.10
19 Aug 2022$5.10
26 Aug 2022$5.10
2 Sep 2022$5.10
9 Sep 2022$5.10
16 Sep 2022$5.10
23 Sep 2022$5.10
30 Sep 2022$5.42
7 Oct 2022$5.42
14 Oct 2022$5.42
21 Oct 2022$5.42
28 Oct 2022$5.42
4 Nov 2022$5.42
11 Nov 2022$5.42
18 Nov 2022$5.42
25 Nov 2022$5.42
2 Dec 2022$5.42
9 Dec 2022$5.42
16 Dec 2022$5.42
23 Dec 2022$5.42
30 Dec 2022$4.98
6 Jan 2023$4.98
13 Jan 2023$4.98
20 Jan 2023$4.98
27 Jan 2023$4.98
3 Feb 2023$4.98
10 Feb 2023$4.98
17 Feb 2023$4.98
24 Feb 2023$4.98
3 Mar 2023$4.98
10 Mar 2023$4.98
17 Mar 2023$4.98
24 Mar 2023$4.98
31 Mar 2023$4.50
6 Apr 2023$4.50
14 Apr 2023$4.50
21 Apr 2023$4.50
28 Apr 2023$4.50
5 May 2023$4.50
12 May 2023$4.50
19 May 2023$4.50
26 May 2023$4.50
2 Jun 2023$4.50
9 Jun 2023$4.50
16 Jun 2023$4.50
23 Jun 2023$4.50
30 Jun 2023$7.61
7 Jul 2023$7.61
14 Jul 2023$7.61
21 Jul 2023$7.61
28 Jul 2023$7.61
4 Aug 2023$7.61
11 Aug 2023$7.61
18 Aug 2023$7.61
25 Aug 2023$7.61
1 Sep 2023$7.61
8 Sep 2023$7.61
15 Sep 2023$7.61
22 Sep 2023$7.61
29 Sep 2023$6.48
6 Oct 2023$6.48
13 Oct 2023$6.48
20 Oct 2023$6.48
27 Oct 2023$6.48
3 Nov 2023$6.48
10 Nov 2023$6.48
17 Nov 2023$6.48
24 Nov 2023$6.48
1 Dec 2023$6.48
8 Dec 2023$6.48
15 Dec 2023$6.48
22 Dec 2023$6.48
29 Dec 2023$5.88
5 Jan 2024$5.88
12 Jan 2024$5.88
19 Jan 2024$5.88
26 Jan 2024$5.88
2 Feb 2024$5.88
9 Feb 2024$5.88
16 Feb 2024$5.88
23 Feb 2024$5.88
1 Mar 2024$5.88
8 Mar 2024$5.88
15 Mar 2024$5.88
22 Mar 2024$5.88
28 Mar 2024$5.50
5 Apr 2024$5.50
12 Apr 2024$5.50
19 Apr 2024$5.50
26 Apr 2024$5.50
3 May 2024$5.50
10 May 2024$5.50
17 May 2024$5.50
24 May 2024$5.50
31 May 2024$5.50
7 Jun 2024$5.50
14 Jun 2024$5.50
21 Jun 2024$5.50
28 Jun 2024$1.20
5 Jul 2024$1.20
12 Jul 2024$1.20
19 Jul 2024$1.20
26 Jul 2024$1.20
2 Aug 2024$1.20
9 Aug 2024$1.20
16 Aug 2024$1.20
23 Aug 2024$1.20
30 Aug 2024$1.20
6 Sep 2024$1.20
13 Sep 2024$1.20
20 Sep 2024$1.20
27 Sep 2024$1.36
4 Oct 2024$1.36
11 Oct 2024$1.36
18 Oct 2024$1.36
25 Oct 2024$1.36
1 Nov 2024$1.36
8 Nov 2024$1.36
15 Nov 2024$1.36
22 Nov 2024$1.36
29 Nov 2024$1.36
6 Dec 2024$1.36
13 Dec 2024$1.36
20 Dec 2024$1.36
27 Dec 2024$2.06
3 Jan 2025$2.06
10 Jan 2025$2.06
17 Jan 2025$2.06
24 Jan 2025$2.06
31 Jan 2025$2.06
7 Feb 2025$2.06
14 Feb 2025$2.06
21 Feb 2025$2.06
28 Feb 2025$2.06
7 Mar 2025$2.06
14 Mar 2025$2.06
21 Mar 2025$2.06
28 Mar 2025$2.20
4 Apr 2025$2.20
11 Apr 2025$2.20
17 Apr 2025$2.20
25 Apr 2025$2.20
2 May 2025$2.20
9 May 2025$2.20
16 May 2025$2.20
23 May 2025$2.20
30 May 2025$2.20
6 Jun 2025$2.20
13 Jun 2025$2.20
20 Jun 2025$2.20
27 Jun 2025$2.34
3 Jul 2025$2.34
11 Jul 2025$2.34
18 Jul 2025$2.34
25 Jul 2025$2.34
1 Aug 2025$2.34
8 Aug 2025$2.34
15 Aug 2025$2.34
22 Aug 2025$2.34
29 Aug 2025$2.34
5 Sep 2025$2.34
12 Sep 2025$2.34
19 Sep 2025$2.34
26 Sep 2025$2.35
3 Oct 2025$2.35
10 Oct 2025$2.35
17 Oct 2025$2.35
24 Oct 2025$2.35
31 Oct 2025$2.35
7 Nov 2025$2.35
14 Nov 2025$2.35
21 Nov 2025$2.35
28 Nov 2025$2.35
5 Dec 2025$2.35
12 Dec 2025$2.35
19 Dec 2025$2.35
26 Dec 2025$1.99
2 Jan 2026$1.99
9 Jan 2026$1.99
16 Jan 2026$1.99
23 Jan 2026$1.99
30 Jan 2026$1.99
6 Feb 2026$1.99
13 Feb 2026$1.99
20 Feb 2026$1.99
27 Feb 2026$1.99
6 Mar 2026$1.99
13 Mar 2026$1.99
20 Mar 2026$1.99
27 Mar 2026$2.08
2 Apr 2026$2.08
10 Apr 2026$2.08
17 Apr 2026$2.08
24 Apr 2026$2.08
1 May 2026$2.08
8 May 2026$2.08
15 May 2026$2.08
22 May 2026$2.08
29 May 2026$2.08
5 Jun 2026$2.08
12 Jun 2026$2.08
18 Jun 2026$2.08
26 Jun 2026$2.10
2 Jul 2026$2.10
10 Jul 2026$2.10
17 Jul 2026$2.10
24 Jul 2026$2.10
31 Jul 2026$2.10
7 Aug 2026$2.10
14 Aug 2026$2.10
21 Aug 2026$2.10
28 Aug 2026$2.10
4 Sep 2026$2.10
11 Sep 2026$2.10
18 Sep 2026$2.10
25 Sep 2026$2.10
2 Oct 2026$2.10
9 Oct 2026$2.10
16 Oct 2026$2.10
23 Oct 2026$2.10
30 Oct 2026$2.10
4 Nov 2026$2.10
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.6 years of history; short peaks above 91× are drawn at the top edge.

PEG 2.14 at the Jul 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 2.14×
  • PEG = 1.0 1.00×
PEG 2.14 at the Jul 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Oct 20216.00×1.00×
Jan 20221.53×1.00×
Apr 20222.19×1.00×
Jul 20220.76×1.00×
Oct 20220.95×1.00×
Jan 20230.62×1.00×
Apr 20231.52×1.00×
Jul 20231.49×1.00×
Oct 20230.51×1.00×
Dec 20234.79×1.00×
Mar 20241.41×1.00×
Jun 20241.22×1.00×
Sep 20241.11×1.00×
Dec 20242.85×1.00×
Mar 20252.42×1.00×
Jun 20252.34×1.00×
Sep 20252.66×1.00×
Dec 20253.51×1.00×
Apr 20262.38×1.00×
Jul 20262.14×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters; values above 6 are drawn at the top edge.
70.6×P/E · higher than 86% of its last 4.6 years
2.61PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved −5.8% while the price moved +75.6%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 3 years the price moved +21.8% a year; about −29.0% a year came from earnings growth and about +50.8 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Is the Revvity business getting better or worse?

Revvity, Inc.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −16.7% in the latest quarter, against +91.5% at its best in 12 quarters, with ROCE steady at 4.1%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +3.7% in FY25, profit −10.8%

  • Revenue growth 3.7%
Growth year by year: revenue +3.7% in FY25, profit −10.8%
QuarterRevenue growth
FY22–
FY23−13.5%
FY23−16.9%
FY240.2%
FY253.7%

Profit growth, EPS growth

  • Profit growth −10.8%
  • EPS growth −5.8%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY22––
FY23−39.7%−44.2%
FY2321.8%23.3%
FY24−61%−60.5%
FY25−10.8%−5.8%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue stabilising, profit rolling over

  • Revenue 4.1%
Three growth lines over twelve quarters: revenue stabilising, profit rolling over
QuarterRevenue
Oct 2023−22.3%
Dec 2023−16.9%
Mar 2024−9.9%
Jun 2024−4.5%
Sep 2024−2.7%
Dec 20240.2%
Mar 20251.6%
Jun 20253.3%
Sep 20253.4%
Dec 20253.7%
Apr 20264.8%
Jul 20264.1%

Profit, EPS

  • Profit −16.7%
  • EPS −10.6%
Profit, EPS
QuarterProfitEPS
Oct 202317.5%18%
Dec 202321.8%22.3%
Mar 2024−84.4%−84.2%
Jun 2024−79.3%−78.9%
Sep 2024−65.7%−65%
Dec 2024−61%−60.1%
Mar 202591.5%94.9%
Jun 202568.3%72.2%
Sep 2025−6.6%−3.5%
Dec 2025−10.8%−5.2%
Apr 2026−16.4%−10.4%
Jul 2026−16.7%−10.6%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 4.1%
ROCE: the return line, worked out each quarter
QuarterROCE
Oct 2023–
Dec 2023–
Mar 20242.9%
Jun 20242.9%
Sep 20243%
Dec 20243.5%
Mar 20253.6%
Jun 20253.6%
Sep 20253.6%
Dec 20253.9%
Apr 20263.9%
Jul 20264.1%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
FlatRevenue growth · latest +4.1%, range −22.3% to +4.8%
FallingProfit growth · latest −16.7%, range −84.4% to +91.5%
FlatEPS growth · latest −10.6%, range −84.2% to +94.9%
Stuck lowROCE · latest 4.1%, range 2.9% to 4.1%

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+3.7%−9.3%——
Profit−10.8%−36.5%——
EPS−5.8%−36.5%——
Stock price+75.6%+21.8%−1.1%+12.1%
+1.3%Revenue growth (Jul 2026) · latest quarter against a year ago
−3.9%Profit growth (Jul 2026) · latest quarter against a year ago
−9.3%Revenue, 3 years · yearly growth over the long run

How much does Revvity earn on its capital?

Revvity, Inc. earned a ROE of 3% in FY25. Its return on capital used (ROIC) is 4.8 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 8.4% net margin and 0.23× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 8.4% net margin × 0.23× asset turnover × 1.68× leverage (assets divided by equity) ≈ 3.2% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 4.5% − 9.3% = −4.8 percentage points. The 9.3% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

FY25: ROE 3%, the full history

  • ROE 3.3%
  • ROIC (annual) 4%
  • Cost of capital 9.3%
FY25: ROE 3%, the full history
QuarterROEROIC (annual)Cost of capital
FY2213.2%12.1%9.3%
FY237.7%3.4%9.3%
FY238.8%3.4%9.3%
FY243.5%3.6%9.3%
FY253.3%4%9.3%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 9.3% cost of capital used on this page.

Jul 2026: ROIC 3.9% (last 12 months) against a 9.3% cost of capital

  • ROIC (12 months) 3.9%
  • ROE (12 months) 2.3%
  • Cost of capital 9.3%
Jul 2026: ROIC 3.9% (last 12 months) against a 9.3% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Oct 20233.7%2.9%9.3%
Dec 20233.3%1.7%9.3%
Mar 20243%3.3%9.3%
Jun 20242.9%1.5%9.3%
Sep 20242.9%3.7%9.3%
Dec 20243.2%4.7%9.3%
Mar 20253.7%4.5%9.3%
Jun 20253.8%2.2%9.3%
Sep 20253.7%2.9%9.3%
Dec 20253.6%2.5%9.3%
Apr 20263.9%5.2%9.3%
Jul 20263.9%2.3%9.3%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Revvity have too much debt?

Revvity, Inc. has total debt of $3.3 B against shareholder equity of $7.2 B as of Jul 2026, so its debt is 0.46× its equity. Year by year, that ratio went from 0.72 in FY22 to 0.47 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $3.4 B, 0.47× equity

  • Total debt $3.4 B
FY25: debt $3.4 B, 0.47× equity
QuarterTotal debt
FY22$5.2 B
FY23$4.6 B
FY23$4.1 B
FY24$3.3 B
FY25$3.4 B

Debt-to-equity

  • Debt-to-equity 0.47×
Debt-to-equity
QuarterDebt-to-equity
FY220.72×
FY230.62×
FY230.52×
FY240.43×
FY250.47×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 5-year window.

Jul 2026: debt $3.3 B, debt-to-equity 0.46

  • Total debt (quarterly) $3.3 B
Jul 2026: debt $3.3 B, debt-to-equity 0.46
QuarterTotal debt (quarterly)
Oct 2023$4.0 B
Dec 2023$4.1 B
Mar 2024$4.0 B
Jun 2024$4.0 B
Sep 2024$3.3 B
Dec 2024$3.3 B
Mar 2025$3.3 B
Jun 2025$3.4 B
Sep 2025$3.4 B
Dec 2025$3.4 B
Apr 2026$3.4 B
Jul 2026$3.3 B

Debt-to-equity

  • Debt-to-equity 0.46×
Debt-to-equity
QuarterDebt-to-equity
Oct 20230.52×
Dec 20230.52×
Mar 20240.51×
Jun 20240.51×
Sep 20240.42×
Dec 20240.43×
Mar 20250.44×
Jun 20250.45×
Sep 20250.46×
Dec 20250.47×
Apr 20260.47×
Jul 20260.46×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the Revvity shareholding pattern?

6.2% of Revvity, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

6.2%Short interest · of the tradable float
2.8Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Revvity from balance-sheet trouble?

For Revvity, Inc., the Z-score is 2.54. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 2.54 is in the grey area, neither clearly safe nor clearly in trouble.

How does Revvity rank in its industry?

59.1 out of 100, rank 6 of 30 in Diagnostics & Research, with 58% of the evidence available.

Revvity, Inc. scores 59.1 out of 100 against the 30 companies it is compared with in Diagnostics & Research, ranking 6. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 20.4 + 12.8 + 8.8 + 17.1 = 59.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Revvity compared with?

Revvity ranks 6 of 30 Diagnostics & Research companies on the 4-Factor Sector Score, with 59.1 out of 100.

  1. 1CareDx, Inc.CDNA · leader · Evidence leans up · 64% evidence62.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 33.9% · Profit 93.1% · Operating margin change 12.6 points · 62% evidenceCapital efficiency 7.2/25 · ROCE -0.4% · Operating margin 0.2% · 76% evidenceValuation 10.6/20 · P/E 13.3× · PEG — · 15% evidenceRelative strength 19.9/20 · Lead over its industry 102.6% · Lead over S&P 500 155% · 1 year 449.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 25.1 + 7.2 + 10.6 + 19.9 = 62.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  2. 2Agilent Technologies, Inc.A · leader · Evidence leans up · 85% evidence61.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 8.6% · Profit 18% · Operating margin change 2.9 points · 95% evidenceCapital efficiency 18.4/25 · ROCE 15.4% · Operating margin 25.6% · 76% evidenceValuation 11.1/20 · P/E 27.1× · PEG 1.41 · 65% evidenceRelative strength 11.3/20 · Lead over its industry -9% · Lead over S&P 500 20.5% · 1 year 20.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 18.4 + 11.1 + 11.3 = 61.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Labcorp Holdings Inc.LH · leader · Evidence leans up · 81% evidence60.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.3/35 · Revenue 6.4% · Profit 31.2% · Operating margin change 0.9 points · 83% evidenceCapital efficiency 13.4/25 · ROCE 9.9% · Operating margin 12.2% · 76% evidenceValuation 15.2/20 · P/E 22.9× · PEG 0.69 · 65% evidenceRelative strength 10.6/20 · Lead over its industry -8.7% · Lead over S&P 500 21.7% · 1 year 45.5% · 100% evidence · 11 of 12 weeks aheadExact sum: 21.3 + 13.4 + 15.2 + 10.6 = 60.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Medpace Holdings, Inc.MEDP · breaking out · Evidence leans up · 85% evidence59.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 20.3% · Profit 19.4% · Operating margin change 1.6 points · 95% evidenceCapital efficiency 21.3/25 · ROCE 75.3% · Operating margin 23.1% · 76% evidenceValuation 12.2/20 · P/E 33.6× · PEG 1.29 · 65% evidenceRelative strength 7.1/20 · Lead over its industry -13.8% · Lead over S&P 500 14.3% · 1 year 11.5% · 100% evidence · 11 of 12 weeks aheadExact sum: 19.1 + 21.3 + 12.2 + 7.1 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5IDEXX Laboratories, Inc.IDXX · turning · Evidence leans up · 81% evidence59.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.1/35 · Revenue 12.8% · Profit 15.5% · Operating margin change 1.4 points · 83% evidenceCapital efficiency 21.3/25 · ROCE 68.1% · Operating margin 35% · 76% evidenceValuation 7.1/20 · P/E 36.4× · PEG 1.97 · 65% evidenceRelative strength 8.0/20 · Lead over its industry -19.4% · Lead over S&P 500 8.7% · 1 year -1.5% · 100% evidence · 1 of 12 weeks aheadExact sum: 23.1 + 21.3 + 7.1 + 8 = 59.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Revvity, Inc. this pageRVTY · leader · Too little evidence to rank firmly · 58% evidence59.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.4/35 · Revenue — · Profit — · Operating margin change 3.3 points · 45% evidenceCapital efficiency 12.8/25 · ROCE 4.3% · Operating margin 17.1% · 76% evidenceValuation 8.8/20 · P/E 53.4× · PEG — · 15% evidenceRelative strength 17.1/20 · Lead over its industry 3.2% · Lead over S&P 500 36% · 1 year 75.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.4 + 12.8 + 8.8 + 17.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  7. 7GRAIL, Inc.GRAL · leader · Evidence leans up · 61% evidence56.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.9/35 · Revenue 23% · Profit — · Operating margin change 36.1 points · 62% evidenceCapital efficiency 3.9/25 · ROCE -19.3% · Operating margin -332% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 19.4/20 · Lead over its industry 27.8% · Lead over S&P 500 66% · 1 year 80.9% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.9 + 3.9 + 10 + 19.4 = 56.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Mettler-Toledo International Inc.MTD · leader · Evidence leans up · 81% evidence55.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.0/35 · Revenue 6.9% · Profit 9% · Operating margin change 3.8 points · 83% evidenceCapital efficiency 21.0/25 · ROCE 47.8% · Operating margin 31.2% · 76% evidenceValuation 6.8/20 · P/E 28.5× · PEG 2.27 · 65% evidenceRelative strength 11.0/20 · Lead over its industry -10.7% · Lead over S&P 500 19% · 1 year 19.7% · 100% evidence · 12 of 12 weeks aheadExact sum: 17 + 21 + 6.8 + 11 = 55.8 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  9. 9Natera, Inc.NTRA · leader · Evidence leans up · 64% evidence54.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.1/35 · Revenue 37.8% · Profit — · Operating margin change 9.9 points · 62% evidenceCapital efficiency 5.3/25 · ROCE -13.5% · Operating margin -10.3% · 76% evidenceValuation 11.4/20 · P/E -152.2× · PEG — · 15% evidenceRelative strength 13.9/20 · Lead over its industry 8.4% · Lead over S&P 500 41.3% · 1 year 95.9% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.1 + 5.3 + 11.4 + 13.9 = 54.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Adaptive Biotechnologies CorporationADPT · leader · Evidence leans up · 64% evidence53.5out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.7/35 · Revenue 51.5% · Profit — · Operating margin change 20.5 points · 62% evidenceCapital efficiency 5.5/25 · ROCE -6.8% · Operating margin -22% · 76% evidenceValuation 10.9/20 · P/E -28.6× · PEG — · 15% evidenceRelative strength 11.4/20 · Lead over its industry 1.5% · Lead over S&P 500 32.3% · 1 year 80.6% · 100% evidence · 11 of 12 weeks aheadExact sum: 25.7 + 5.5 + 10.9 + 11.4 = 53.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11Quest Diagnostics IncorporatedDGX · leader · Evidence leans up · 85% evidence53.3out of 100GrowthCapitalValuationRelative
  12. 12Sotera Health CompanySHC · quiet · Evidence leans up · 71% evidence51.3out of 100GrowthCapitalValuationRelative
  13. 13Charles River Laboratories International, Inc.CRL · leader · Evidence leans up · 64% evidence50.2out of 100GrowthCapitalValuationRelative
  14. 14IQVIA Holdings Inc.IQV · leader · Evidence leans down · 81% evidence49.2out of 100GrowthCapitalValuationRelative
  15. 15BillionToOne, Inc.BLLN · turning · Too little evidence to rank firmly · 58% evidence49.1out of 100GrowthCapitalValuationRelative
  16. 16OPKO Health, Inc.OPK · turning · Evidence leans down · 64% evidence48.7out of 100GrowthCapitalValuationRelative
  17. 17Veracyte, Inc.VCYT · turning · Evidence leans down · 64% evidence48.6out of 100GrowthCapitalValuationRelative
  18. 18Danaher CorporationDHR · breaking out · Evidence leans down · 85% evidence48.4out of 100GrowthCapitalValuationRelative
  19. 19NeoGenomics, Inc.NEO · losing its lead · Evidence leans down · 64% evidence47.4out of 100GrowthCapitalValuationRelative
  20. 20Twist Bioscience CorporationTWST · leader · Evidence leans down · 64% evidence46.6out of 100GrowthCapitalValuationRelative
  21. 21Guardant Health, Inc.GH · turning · Evidence leans down · 61% evidence46.1out of 100GrowthCapitalValuationRelative
  22. 22RadNet, Inc.RDNT · breaking out · Evidence leans down · 64% evidence46.0out of 100GrowthCapitalValuationRelative
  23. 23Illumina, Inc.ILMN · leader · Evidence leans down · 71% evidence45.1out of 100GrowthCapitalValuationRelative
  24. 24Thermo Fisher Scientific Inc.TMO · leader · Evidence leans down · 85% evidence44.6out of 100GrowthCapitalValuationRelative
  25. 25Qiagen N.V.QGEN · breaking out · Evidence leans down · 81% evidence44.3out of 100GrowthCapitalValuationRelative
  26. 26Waters CorporationWAT · leader · Too little evidence to rank firmly · 58% evidence40.0out of 100GrowthCapitalValuationRelative
  27. 27ICON Public Limited CompanyICLR · turning · Evidence leans down · 81% evidence37.9out of 100GrowthCapitalValuationRelative
  28. 28Castle Biosciences, Inc.CSTL · breaking out · Evidence leans down · 64% evidence35.4out of 100GrowthCapitalValuationRelative
  29. 29Personalis, Inc.PSNL · turning · Most evidence points down · 61% evidence33.4out of 100GrowthCapitalValuationRelative
  30. 30GeneDx Holdings Corp.WGS · quiet · Most evidence points down · 71% evidence24.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Diagnostics & Research, all 30 compared on one page.

Which companies are close to Revvity in size?

Revvity is the 14th largest of 34 Diagnostics & Research companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Quest Diagnostics Incorporated, Guardant Health, Inc. and Medpace Holdings, Inc. Just below it: Charles River Laboratories International, Inc., ICON Public Limited Company and Qiagen N.V.

Diagnostics & Research companies close in size

  1. Quest Diagnostics Incorporated $28.1 billion
  2. Guardant Health, Inc. $22.6 billion
  3. Medpace Holdings, Inc. $18.4 billion
  4. Revvity, Inc. $17.8 billion
  5. Charles River Laboratories International, Inc. $15.6 billion
  6. ICON Public Limited Company $15.2 billion
  7. Qiagen N.V. $10.5 billion

All 34 Diagnostics & Research companies, largest first

Companies close in size in other industries

  1. Jones Lang LaSalle Incorporated $17.8 billion · Real Estate Services
  2. MACOM Technology Solutions Holdings, Inc. $17.8 billion · Semiconductors
  3. Revvity, Inc. $17.8 billion
  4. Plains All American Pipeline, L.P. $17.8 billion · Oil & Gas Midstream
  5. Hyatt Hotels Corporation $17.8 billion · Lodging

What else do people ask about Revvity?

What were Revvity's latest quarterly results?

Revvity, Inc. reported revenue of $730 M and net profit of $51.8 M for the Jul 2026 quarter. Revenue rose 1.3% and profit fell 3.9% compared with a year earlier. Earnings per share were $0.46.

The operating margin was 17.1%, 2.8 percentage points higher than a year earlier (as of 4 November 2026).

What is Revvity's market cap?

Revvity, Inc.'s market capitalisation is $17.8 B at a stock price of $159.43. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Revvity performing?

Revvity, Inc.'s share price has been rising for 19 weeks. In its latest quarter, revenue rose 1.3% and profit fell 3.9% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 22 weeks running (as of 4 November 2026).

Will Revvity's stock price go up?

This page does not forecast Revvity, Inc.'s stock price. What it shows instead: the stock price is $159.43, and it has been rising for 19 weeks. Its P/E of 70.6× is higher than 86% of its own last 5 years (as of 4 November 2026).

Does Revvity have too much debt?

Revvity, Inc. has a moderate amount of debt: its debt is 0.38× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026).

Where is Revvity in its business cycle?

Revvity, Inc.'s FY25 operating margin was 15.3%, against a 5-year range of 13.9% to 37.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 17.1%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Revvity story?

The main question: the share price moved +75.6% in a year while yearly earnings per share moved −5.8%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Revvity a stock worth studying right now?

What the numbers show: Revvity, Inc.'s share price has risen faster than its earnings: +75.6% in a year, against −5.8% for earnings per share. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.